Laddar...
The impact of co-administration of ketoconazole and rifampicin on the pharmacokinetics of apremilast in healthy volunteers
AIMS: Two clinical studies were conducted to determine possible drug−drug interactions between apremilast and a strong CYP3A4 inhibitor, ketoconazole, or a potent CYP3A4 inducer, rifampicin. The main objectives of these two studies were to evaluate the impact of multiple doses of ketoconazole on the...
Sparad:
| I publikationen: | Br J Clin Pharmacol |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BlackWell Publishing Ltd
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4238785/ https://ncbi.nlm.nih.gov/pubmed/24962564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12448 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|